Showing 3 of 3 recruiting trials for “Fetal and neonatal alloimmune thrombocytopenia”
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 22 sites📅 Started Feb 2025View details ↗
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 21 sites📅 Started Nov 2024View details ↗
RecruitingNCT04598750 ↗
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →